Diabetes drugs test a new side effect: slowing down symptoms of Parkinson’s
On April 26, at a special news event in Science magazine, two scientists specializing in GLP-1 receptor agonists answered questions from journalists via videoconference. Most queries were about diabetes and obesity. These drugs have revolutionized the …